Little T agree, T/0 price is hard to predict,
I like to think of Neuren's valuation as pre FDA approval and post FDA approval.
A T/O valuation pre FDA approval will be vastly different to one after. I'm hoping we are still around to see the full potential of this company with milestone payments and double digit royalties. Valuation $15 to $20 after Trofs approval.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.31%
!
$17.78

Share Price, page-586
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.78 |
Change
0.230(1.31%) |
Mkt cap ! $2.240B |
Open | High | Low | Value | Volume |
$17.83 | $17.99 | $17.35 | $16.12M | 911.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11000 | $17.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.80 | 10070 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11000 | 17.400 |
2 | 2732 | 17.300 |
1 | 300 | 17.100 |
1 | 58 | 17.060 |
1 | 10 | 17.040 |
Price($) | Vol. | No. |
---|---|---|
17.800 | 70 | 1 |
17.940 | 566 | 1 |
17.990 | 73 | 1 |
18.000 | 4313 | 4 |
18.100 | 611 | 2 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
NEU (ASX) Chart |